Clinical trial 2025-524439-38-00 · Non Small Cell Lung Cancer (NSCLC)
Oncology research
21 Sep 2026
Clinical trial 2025-524439-38-00 (phase II) is «authorised» on CTIS (EU Clinical Trials Information System).
Condition: Non Small Cell Lung Cancer (NSCLC) · Registered interventions: IMFINZI 50 mg/mL concentrate for solution for infusion · Recorded dates (source): 2026-09-16, 2026-09-18.
Source: https://euclinicaltrials.eu/ctis-public/view/2025-524439-38-00